Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol
oleh: Yan-Ming Zeng, Xiao-Lei Xu, Xiao-Qing He, Sheng-Quan Tang, Yao Li, Yin-Qiu Huang, Vijay Harypursat, Yao-Kai Chen, Peng Lyu
| Format: | Article |
|---|---|
| Diterbitkan: | Wolters Kluwer 2020-05-01 |
Deskripsi
No description available for this item.